BofA warns Fed risks policy mistake with early rate cuts
David Jeffrey Katz, Executive Vice President and Chief Legal Officer at RadNet, Inc. (NASDAQ:RDNT), a $5.29 billion medical diagnostic imaging services provider, sold 17,000 shares of common stock on August 13, 2025. The sales totaled $1.16 million, coming at a time when the stock has seen a remarkable 28.84% gain over the past week.
The shares were sold at weighted average price of $68.31, in multiple transactions at prices ranging from $68.02 to $68.54. Following the transaction, Katz directly owns 86,774 shares of RadNet . According to InvestingPro analysis, the stock is currently trading above its Fair Value, with technical indicators suggesting overbought conditions. While the company wasn’t profitable in the last twelve months, analysts expect it to turn profitable this year. For deeper insights and access to 12 additional exclusive ProTips for RDNT, visit InvestingPro.
In other recent news, RadNet Inc. reported strong financial results for the second quarter of 2025, significantly surpassing earnings expectations. The company’s earnings per share more than doubled the forecast, and revenue also exceeded projections. Following these results, Raymond James raised its price target for RadNet to $75 from $66, maintaining a Strong Buy rating. The company’s adjusted EBITDA came in at $81.2 million, beating analyst expectations of $77.4 million. Management has raised its adjusted EBITDA guidance by $3 million to a range of $286-296 million, with the increase attributed to its core imaging segment. These developments indicate a robust performance for RadNet, as reflected in the positive market response.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.